Additional file 5: Figure S3. of Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody
- Yvonne Jauw (4787391)
- Marc Huisman (180686)
- Tapan Nayak (570788)
- Danielle Vugts (4787403)
- Randolph Christen (4787397)
- Valerie Naegelen (4787385)
- Dominik Ruettinger (4787394)
- Florian Heil (4787400)
- Adriaan Lammertsma (3763888)
- Henk Verheul (4787388)
- Otto Hoekstra (3552038)
- Guus van Dongen (3552047)
- C. Menke-van der Houven van Oordt (4787406)
Publication date
January 2018
DOIAbstract
Additional examples of focal tumour uptake of 89Zr-RG7356 at 96Â h p.i.. From left to right: low dose CT, attenuation-corrected PET and fused image. (a) Tumour lesion: left side of the skull (patient 8, 450Â mg cohort). (b) Tumour lesion: sacrum (patient 13, 675Â mg cohort). (TIFF 6335Â kb
Add to ORKG